Hubei Hongyuan Pharmaceutical Co., Ltd. (301246)

Overview

Hubei Hongyuan Pharmaceutical Technology Co., Ltd. is a reputable entity in the pharmaceutical sector, specializing in the manufacturing and distribution of pharmaceutical products both in China and on an international scale. Established in 2002 and operating from its headquarters in Huanggang, China, the company has expanded its reach and influence through a network of subsidiaries. It boasts a comprehensive portfolio that encompasses the development, production, and sale of a variety of pharmaceutical ingredients and products catering to the needs of the healthcare industry globally.

Products and Services

The company’s offerings are diverse, covering critical areas of the pharmaceutical industry, which include:

• Active Pharmaceutical Ingredients (APIs): Such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir. These compounds are foundational for creating effective medications, demonstrating the company’s capacity to support the pharmaceutical industry's needs for essential drug components.
• Pharmaceutical Intermediates: Including glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, triamine, diacetyl guanine, guanine, and diacetylacyclovir. These intermediates are crucial for the synthesis of APIs, showcasing the company's vital role in the pharmaceutical supply chain.
• Organic Chemical Raw Materials: Comprising fluoride salts, glyoxal, and oxalic acid. These materials serve a variety of purposes across different industries, including pharmaceuticals, indicating the company's broad market appeal and the versatility of its product line.
• New Energy Materials: Consisting of lithium hexafluorophosphate. This product highlights the company’s innovation and its venture into materials that support new energy technologies, such as lithium-ion batteries, aligning with global trends towards renewable energy and sustainability.